Cryptolepis Buchanani

Cryptolepis buchanani  Roem. & Schult.

1. Taxonomic, Nomenclature & Therapeutic Summary Table

Botanical Attribute Pharmacognostic & Therapeutic Specification
Family Asclepiadaceae; Periplocaceae.
Habitat Throughout India.
English Indian Sarsaparilla (black var.).
Ayurvedic Krishna Saarivaa, Jambupatraa Saarivaa, Karantaa, Shyamalataa, Shyaama, Gopi, Gopavadhu, Kaalghatika.
Siddha / Tamil Maattan-kodi, Paal-Kodi, Kattupala.
Folk Karantaa, Anantamuula (Varanasi).
Action Blood-purifier, alterative. Used for rickets in children. In combination with Euphorbia microphylla, the herb is used as a galactagogue. A decoction of the stem is used as a supporting drug in paralysis; of the root bark in rheumatism.
Dosage Root—5–10 g (API Vol. IV.); infusion—50–100 ml. (CCRAS.)
Taxonomic Cohort Genus Cryptolepis (1 documented species); Family Asclepiadaceae (24 documented species).

2. Classical Nomenclature, Taxonomy & Biogeographical Context

Cryptolepis buchanani (taxonomically cited with authority Roem. & Schult.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Asclepiadaceae; Periplocaceae (primary family classification: Asclepiadaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: Throughout India.

Across classical and vernacular Indian systems of medicine, Cryptolepis buchanani is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Indian Sarsaparilla (black var.); in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Krishna Saarivaa, Jambupatraa Saarivaa, Karantaa, Shyamalataa, Shyaama, Gopi, Gopavadhu, Kaalghatika; in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Maattan-kodi, Paal-Kodi, Kattupala; in regional Indian folk and vernacular ethnobotany as Karantaa, Anantamuula (Varanasi). Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.

3. Therapeutic Actions, Phytochemistry & Pharmacological Profile

In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Cryptolepis buchanani are: Blood-purifier, alterative. Used for rickets in children. In combination with Euphorbia microphylla, the herb is used as a galactagogue. A decoction of the stem is used as a supporting drug in paralysis; of the root bark in rheumatism. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.

Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Cryptolepis buchanani establish the following evidence base: The major constituent of the root extract is germanicol docosanoate. The roots contains cryptanoside C. The leaves gave cryptanoside A and B and a cardenolide, cryptosin.

In specialized pharmacognostic classifications, Cryptolepis buchanani is also recognized among important classical herbs with divergent regional plant sources across North and South Indian formularies.

image2

Botanical Reference 1: Cryptolepis buchanani — Wikimedia Commons

image3

Botanical Reference 2: Cryptolepis buchanani — Wikimedia Commons

image4

Botanical Reference 3: Cryptolepis buchanani — Wikimedia Commons

4. Comparative Genus & Family Pharmacognosy

Within Indian medicinal flora, Cryptolepis buchanani stands as a distinct representative of the genus Cryptolepis. Its therapeutic profile underscores the role of selectively utilized medicinal genera alongside larger polytypic genera.

At the family level, Asclepiadaceae encompasses 24 documented medicinal species (1.32% of the 1,814-species flora). Other representative medicinal members of Asclepiadaceae include: Asclepias curassavica (Kaakanaasikaa), Calotropis gigantea (Alarka), Calotropis procera (Alarka), Ceropegia juncea (Kanvel), Decalepis hamiltonii. In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

image1

Figure 1: Quantitative documentation profile across all 24 medicinal species of family Asclepiadaceae.

5. Pharmacopoeial Standards, Posology & Reference Framework

For clinical and traditional dispensing, the standardized posology and crude herb dosage for Cryptolepis buchanani are prescribed as follows: Root—5–10 g (API Vol. IV.); infusion—50–100 ml. (CCRAS.). Crude drug dosages are calibrated against The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and the Standard Nomenclature of Ayurvedic Medicinal Plants published by the Central Council for Research in Ayurveda and Siddha (CCRAS). Classical and modern pharmacognostic synchronization for Cryptolepis buchanani integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.

Scroll to Top